Research on the Construction and Evaluation of Active Monitoring Model ofAdverse Drug Reactions by Marketing Authorization Holder

Chen Zitao, Lai Yunfeng, Chen Xinlin, Xu Xingying, Zhang Guilan, Xu Mengdan

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (3) : 261-268.

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (3) : 261-268. DOI: 10.16153/j.1002-7777.2024.03.004
Supervision Administration

Research on the Construction and Evaluation of Active Monitoring Model ofAdverse Drug Reactions by Marketing Authorization Holder

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 38(3): 261-268 https://doi.org/10.16153/j.1002-7777.2024.03.004

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉